Current Setup & Catalysts
Current Setup & Catalysts — What Updates the Thesis Next
1. Current Setup in One Page
The stock is sitting on a fresh 52-week low at $32.38 ten days after the Q3 FY2026 print (May 21, 2026) that delivered a modest beat (+2.1% revenue, $0.43 EPS vs $0.41 consensus), and the market is mostly watching whether the US service-revenue line stops bleeding and whether the $1.6B-in-9M buyback pace continues. The recent setup is mixed-leaning-quiet: one revenue contraction (Q2 FY26, -3.6%), one mild recovery (Q3 FY26, +2.1%), 9-month revenue down 0.2%, and operating income essentially flat — paired with a +18% international segment and the first material capital-return program in company history. The next real underwriting update is Q4 FY26 earnings in early September 2026, when the FY25 hurricane base lifts and the question of whether the FY26 air pocket was cyclical or structural becomes harder to defer. The single highest-impact near-term event that could update the long-term thesis is not the print itself but the FY26 10-K Note 15 disclosure on the DOJ AML investigation, which would either reaffirm a 24-month footnote risk or escalate to a stage that touches the international buyer pool.
Recent Setup Rating
Hard-Dated Events (Next 6M)
High-Impact Catalysts
Days to Next Hard Date
9M FY26 Revenue YoY
9M FY26 Buyback ($M)
Diluted Share Count YoY (Q3)
Net Cash After Buyback ($M)
P/E (TTM)
The current debate in one sentence. Either US service revenue troughs in 1H FY27 and the multiple re-rates back toward its 10-year comp, or US weakness persists into a third consecutive year and the multiple keeps drifting toward the LKQ-style 13-15x range — and the FY26 10-K Note 15 disclosure on the DOJ AML matter is the one event in the next six months that could shift either path in a non-cyclical way.
2. What Changed in the Last 3-6 Months
The recent narrative arc has three legs, all observable in filings: the first revenue contraction of the modern era (Q2 FY26, reported Feb 19, 2026), a mild recovery print (Q3 FY26, reported May 21, 2026), and the continuation of the largest buyback in company history (cumulative $1.633B in 9M FY26). The tape responded to each: the stock has fallen from ~$50 in mid-2025 to $32 today, with the most decisive distribution session on May 23, 2025 (-11.5% on 3.94x volume) — the inflection that started the 12-month downtrend.
The narrative arc since May 2025: investors were paying ~30x for a 13%-revenue-growth, 37%-margin compounder. They watched volume growth decelerate quarter after quarter, then saw the first negative print since the pandemic in Q2 FY26 paired with the largest buyback in company history. They now pay ~20x for a stock with the same 36% operating margin, the same 30% ROIC, and a more shareholder-friendly capital policy — but with twelve consecutive months of declining-to-flat US service revenue and a never-resolved DOJ investigation parked in the footnotes. The earlier worry was "what will Copart do with $5B of cash"; the current worry is "is the US business broken, and does the DOJ matter end with a consent decree that restricts the international growth lever."
3. What the Market Is Watching Now
The five live watchpoints split into one high-frequency signal (US service revenue, every 90 days), two event-driven signals (DOJ resolution language, comp committee decision), and two cycle-period signals (buyback cadence, hurricane CAT). The US-service-revenue line is the most observable and the most under-explained; management has declined to comment publicly on it for three consecutive quarters. Everything else is currently absorbing into the price; this is the one variable the price action is actively betting on.
4. Ranked Catalyst Timeline
Single highest-impact event in the next six months. The FY26 10-K Note 15 language on the DOJ Consumer Protection Branch AML investigation. The investigation has been disclosed in identical language for two consecutive 10-Ks (FY24 and FY25). A third year of identical language is a non-event; any material change — a charging document, a consent decree, a quantified accrual, or its quiet removal — would update the long-term thesis. No public timeline exists.
5. Impact Matrix
The six catalysts that update durable thesis variables sort into one regulatory event (DOJ), one earnings sequence (Q4/Q1 print pair), one capital allocation pattern (buyback cadence), one competitive disclosure (RBA segments), one governance event (Liaw grant), and one cycle test (hurricane season). Among these, the DOJ matter is the only event that could change the long-term thesis without first appearing in financials. Everything else has been visible to investors for at least two quarters and the price has partly absorbed it.
6. Next 90 Days
The 90-day map is back-loaded. The first 60-65 days are quiet on hard dates — the calendar between now and late August 2026 is mostly tape-watching, consensus-tracking, and hurricane monitoring. The cluster of decision-relevant events lands in early-to-late September 2026: Q4 earnings around Sept 3, and the FY26 10-K filing within ~60 days of fiscal year-end (typically late Sep). A PM not currently in CPRT does not need to be — the meaningful underwriting update arrives in roughly 90-100 days.
7. What Would Change the View
Three observable signals would most change the investment debate over the next six months. First, US service revenue printing positive YoY in both Q4 FY26 (Sept 2026) and Q1 FY27 (Nov 2026) — that single combination would convert the FY26 air pocket from "structural break" back to "cyclical inflection", validate the load-bearing MD&A line that total-loss frequency keeps rising, and re-open the 25x base case in numbers-claude.md §7. Second, the FY26 10-K Note 15 disclosure on the DOJ Consumer Protection Branch AML matter — a quiet removal or KYC-only resolution would lift a 24-month footnote risk and reaffirm the international buyer pool that drives 38.8% of US unit sales, while any consent-decree language restricting onboarding would directly compress the largest long-term revenue-per-car lever and align with the bear case in bear-claude.md §3. Third, the buyback cadence over Q4 FY26 and Q1 FY27: a sustained $400M+/quarter pace alongside a multi-year framework disclosed in 10-K MD&A would confirm the capital pivot is structural (the single largest swing factor in the long-term compounding math per long-term-thesis-claude.md §3), while a drop below $300M/quarter would suggest the pivot was reactive to the multiple, not durable. Two of these three signals point the same direction over the next two prints; the third is the only one that can update the thesis without earnings. The current setup is quiet enough that none of these has been pre-traded into the multiple.